GCP
MRK icon

Gill Capital Partners’s Merck MRK Stock Holding History

Gill Capital Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$51.2K Buy
+426
New +$49.2K 0.01% 262

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Gill Capital Partners's MRK Position: Q1 2026 in Review

Gill Capital Partners opened a new position in Merck (MRK) in Q1 2026: 426 shares worth $51.2K. The stake represents 0.01% of the portfolio and ranks #262 among its holdings.

3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Gill Capital Partners held 426 shares of Merck worth $51.2K as of Q1 2026.
  • Merck was a new Gill Capital Partners position in Q1 2026.
  • Merck made up 0.01% of Gill Capital Partners's portfolio in Q1 2026, its #262 holding.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Gill Capital Partners's 13F filing for Q1 2026, filed 13 Apr 2026.